These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17558046)

  • 1. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies.
    Lakshmi PK; Devi GS; Bhaskaran S; Sacchidanand S
    Indian J Dermatol Venereol Leprol; 2007; 73(3):157-61. PubMed ID: 17558046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting.
    Ali MF; Salah M; Rafea M; Saleh N
    Med Sci Monit; 2008 Dec; 14(12):PI66-74. PubMed ID: 19043379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Nordstrom CG; Ali SM
    J Cutan Med Surg; 2001; 5(4):299-302. PubMed ID: 11907839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial.
    Papp K; Thaçi D; Marcoux D; Weibel L; Philipp S; Ghislain PD; Landells I; Hoeger P; Kotkin C; Unnebrink K; Seyger M; Williams D
    Lancet; 2017 Jul; 390(10089):40-49. PubMed ID: 28478975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
    Chandra A; Aggarwal G; Manchanda S; Narula A
    Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 0.25% methotrexate gel in a hydrogel base for palmoplantar psoriasis.
    Kumar B; Sandhu K; Kaur I
    J Dermatol; 2004 Oct; 31(10):798-801. PubMed ID: 15672706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery.
    Ourani-Pourdashti S; Mirzaei E; Heidari R; Ashrafi H; Azadi A
    Int J Biol Macromol; 2022 Jul; 213():1115-1126. PubMed ID: 35691430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
    Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical study to determine the efficacy and safety of 1% methotrexate/Azone (MAZ) gel applied topically once daily in patients with psoriasis vulgaris.
    Sutton L; Swinehart JM; Cato A; Kaplan AS
    Int J Dermatol; 2001 Jul; 40(7):464-7. PubMed ID: 11679005
    [No Abstract]   [Full Text] [Related]  

  • 15. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model.
    Bahramizadeh M; Bahramizadeh M; Kiafar B; Jafarian AH; Nikpoor AR; Hatamipour M; Esmaily H; Rezaeemehr Z; Golmohammadzadeh S; Moosavian SA; Jafari MR
    Int J Pharm; 2019 Oct; 569():118623. PubMed ID: 31419462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.
    Karamata VV; Gandhi AM; Patel PP; Sutaria A; Desai MK
    Indian J Pharmacol; 2017; 49(1):84-88. PubMed ID: 28458428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life.
    Ho SG; Yeung CK; Chan HH
    Clin Exp Dermatol; 2010 Oct; 35(7):717-22. PubMed ID: 19925489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
    de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
    Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.